These guidelines aim to provide a strategic approach to reducing morbidity and mortality related to TB and HIV among at-risk drug users and their communities in a way that promotes holistic and person-centered services. They are intended for professionals dealing with the drug users who have the most problematic patterns of use and who have the greatest risk of HIV and TB, especially those who inject drugs.